Arcutis Biotherapeutics, Inc. (ARQT)
26.23
-0.35
(-1.32%)
USD |
NASDAQ |
Oct 12, 16:00
26.23
0.00 (0.00%)
After-Hours: 19:11
Arcutis Biotherapeutics Free Cash Flow (Quarterly) : 12.48M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.48M |
| March 31, 2026 | 2.239M |
| December 31, 2025 | 26.18M |
| September 30, 2025 | -1.754M |
| June 30, 2025 | -9.754M |
| March 31, 2025 | -30.99M |
| December 31, 2024 | -5.748M |
| September 30, 2024 | -34.83M |
| June 30, 2024 | -45.12M |
| March 31, 2024 | -31.60M |
| December 31, 2023 | -56.25M |
| September 30, 2023 | -44.05M |
| June 30, 2023 | -66.76M |
| March 31, 2023 | -80.43M |
| December 31, 2022 | -71.19M |
| September 30, 2022 | -75.20M |
| Date | Value |
|---|---|
| June 30, 2022 | -62.06M |
| March 31, 2022 | -57.10M |
| December 31, 2021 | -51.97M |
| September 30, 2021 | -41.02M |
| June 30, 2021 | -35.87M |
| March 31, 2021 | -46.76M |
| December 31, 2020 | -32.25M |
| September 30, 2020 | -34.27M |
| June 30, 2020 | -25.78M |
| March 31, 2020 | -21.05M |
| December 31, 2019 | -18.16M |
| September 30, 2019 | -10.95M |
| June 30, 2019 | -8.171M |
| March 31, 2019 | -7.257M |
| December 31, 2018 | -5.838M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Insmed, Inc. | -95.09M |
| Emergent BioSolutions, Inc. | 54.00M |
| Exelixis, Inc. | 300.92M |
| Puma Biotechnology, Inc. | 1.624M |